Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo

Transplantation

Volumn 69, Issue 4, 2000, Pages 605-609

  Krieger, Nancy R ^a   Fathman, C Garrison ^b   Shaw, Michael K ^b   Ridgway, William M ^b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; HERMES ANTIGEN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE CELL; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TISSUE SPECIFICITY;

EID: 0034056752     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002270-00023     Document Type: Article

References (38)

1. Ridgway W, Fasso M, Fathman CG. Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. J Immunol 1998; 161: 714.
2. Shizuru JA, Gregory AK, Tien-Bao C, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
3. Yin DP, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 6339.
4. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988; 46: 128S.
5. Chen Z, Cobbold S, Metcalfe S, Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992; 22: 805.
6. Han WR, Mottram PL, McKenzie IFC. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model. Transplant Proc 1993; 25: 2933-293.
7. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 1984; 312: 548.
8. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323: 164.
9. Alters SE, Song HK, Fathman CG. Evidence that clonal anergy is induced in thymic migrant cells after anti-CD4-mediated transplantation tolerance. Transplantation 1993; 56: 633.
10. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987; 17: 1159.
11. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretherapy and depletive anti-CD4 antibody depends on CD4+ T cell recognition during the induction phase of the response. Eur J Immunol 1995; 25: 2643.
12. Pearson TC, Darby CR, Buchell AR, West LS, Morris PJ, Wood KJ. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 1993; 55: 361.
13. Mottram PL, Purcell LJ, Pietersz GA, McKenzie IFC. Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model. Transplant Proc 1993; 25: 2935.
14. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990; 20: 2747.
15. Yamamoto H, Monden M, Kawai M, et al. The role of CD8+ and CD4+ cells in islet allograft rejection. Transplantation 1990; 50: 120.
16. a donors. Diabetes 1993; 42: 44.
17. Lowry RP, Forbes RD, Blackburn JH, Marghesco DM. Immune mechanisms in organ allograft rejection. V. Pivitol role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat. Transplantation 1985; 40: 545.
18. Rosenberg AS, Mizouch T, Sharrow SO, Singer A. Phenotype specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.
19. Rosenberg AS, Mizoughi T, Singer A. Evidence for involvement of dual function T cells in rejection of MHC class I disparate skin grafts: assessment of MHC class I alloantigens as in vivo helper determinants. J Exp Med 1988; 168: 33.
20. Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets: II. In vivo responses to class I vs class II H-2 differences. J Exp Med 1986; 165: 1296.
21. Krieger N, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for heart and skin allograft rejection. J Exp Med 1996; 164: 2013.
22. Krieger NR, Fathman CG. The use of CD4 and CD8 knockout mice to study the role of T cell subsets in allotransplant rejection. J Heart Lung Transplant 1997; 16: 263.
23. Ljunggren H, Van Kaer L, Sabatine MS, Auchincloss H, Tonegawa S, Ploegh HL. MHC class I expression and CD8+ T cell development in TAP/B2-microglobulin double mutant mice. Int Immunol 1995; 7: 975.
24. Hergueux J, Bodmer H, Cardell S, et al. Knock-out mice: a new tool for transplantation immunologists. Transplant Proc 1993; 25: 30.
25. Peugh WN, Superine RA, Wood KJ, Morris PJ. The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts. Immunogenetics 1986; 23: 30.
26. Burdick JF, Clow LW. Rejection of murine cardiac allografts: I. Relative role of major and minor antigens. Transplantation 1986; 42: 67.
27. Stepkowski SM, Raza-Ahmad A, Duncan WR. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice. Transplantation 1987; 44: 753.
28. Wang Y, Mayne A, Sell MK, Ahmed-Ansari A. The influence of MHC non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue. Transplantation 1990; 50: 313.
29. Roser BJ. Cellular mechanisms in neonatal and adult tolerance. Immunol Rev 1989; 107: 179.
30. Rahemtulla A, Fung-Leung W, Schilham MW, et al. Normal development and function of CD8+ cells but marked decreased helper cell activity in mice lacking CD4. Nature 1991; 353: 180.
31. Fung-Leung W, Schilham MW, Rahemtulla A, et al. CD8 is needed for development of cytotoxic T cells but not helper cells. Cell 1991; 65: 443.
32. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994; 180: 631.
33. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993; 177: 845.
34. Cosulich ME, Rubartelli A, Risso A, Cozzolino F, Bargellesi A. Functional characterization of an antigen involved in early step of T-cell activation. Proc Natl Acad Sci 1987; 84: 4205.
35. Yokoyama WM, Koning F, Kehn PJ, et al. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J Immunol 1988; 141: 369.
36. Bradley LM, Duncan DD, Tonkonogy S, Swain SL. Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14, CD45RB-helper cells that secretes interleukin 2 (IL-2), IL-3, Il-4, and interferon gamma. J Exp Med 1991; 174: 547.
37. Swain SL, Weinberg AD, English M. CD4+ T cell subsets: lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. J Immunol 1990; 144: 1788.
38. Bradley LM, Atkins GG, Swain SL. Long-term CD4+ memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J Immunol 1992; 148: 324.